1. Moorthy A, Venugopal DC, Shyamsundar V, Madhavan Y, Ravindran S, Kuppuloganathan M, et al. Identification of EGFR as a Biomarker in Saliva and Buccal Cells from Oral Submucous Fibrosis Patients-A Baseline Study. Diagnostics 2022;12(8),1935 [DOI:10.3390/diagnostics12081935] [PMID] [PMCID]

2. 2Adorno-Farias D, Badilla SM, Vidal GP, Fernandez-Ramires R. Epidermal Growth Factor Receptor (EGFR) is Overexpressed in Both Dysplasia and Neoplastic Oral Diseases. OMPJ 2022;13(2):73-78

3. Tan Y, Yan B, Xue L, Li Y, Luo X, Ji P. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma. Lipids Health Dis. 2017;16(1):73 [DOI:10.1186/s12944-017-0465-y] [PMID] [PMCID]

4. Bakhtiari S, Mortazavi H, Mehdipour M, Jafarian N, Ranjbari N, Rahmani S. Frequency of Head and Neck Squamous Cell Carcinomas and Related Variables in Southern Iran (Ahvaz City): 10-Year Retrospective Study. Asian Pac. J. Cancer Prev. 2017;18(2):375-9

5. Yang Q, Guo B, Sun H, Zhang J, Liu S, Hexige S, et al. Identification of the key genes implicated in the transformation of OLP to OSCC using RNA-sequencing. Oncol. Rep. 2017;37(4):2355-65 [DOI:10.3892/or.2017.5487] [PMID]

6. Lorini L, Bescós Atín C, Thavaraj S, Müller-Richter U, Alberola Ferranti M, Pamias Romero J, et al. Overview of oral potentially malignant disorders: from risk factors to specific therapies. Cancers 2021;13(15):3696 [DOI:10.3390/cancers13153696] [PMID] [PMCID]

7. Hwang JT, Gu YR, Shen M, Ralhan R, Walfish PG, Pritzker KP, et al. Individualized five-year risk assessment for oral premalignant lesion progression to cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(3):374-81 [DOI:10.1016/j.oooo.2016.11.004] [PMID]

8. Neville BW, Damm DD, Chi AC, Allen CM. Oral and maxillofacial pathology: Elsevier Health Sciences; 2016.

9. Ramos‐García P, González‐Moles MÁ, Warnakulasuriya S. Oral cancer development in lichen planus and related conditions-3.0 evidence level: a systematic review of systematic reviews. Oral Dis.2021;27(8):1919-1935.‏ [DOI:10.1111/odi.13812] [PMID]

10. Giuliani M, Troiano G, Cordaro M, Corsalini M, Gioco G, Lo Muzio L, et al. Rate of malignant transformation of oral lichen planus: A systematic review. Oral Dis.2019; 25(3):693-709.‏ [DOI:10.1111/odi.12885] [PMID]

11. Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: A meta-analysis of 20095 patient data. Oral Oncol. 2017;68:92-102 [DOI:10.1016/j.oraloncology.2017.03.012] [PMID]

12. Parakh MK, Ulaganambi Sh, Ashifa N, Premkumar R, Jain Amit L. Oral potentially malignant disorders. Eur. J. Cancer Prev. 2020. 29(1): 65-72 [DOI:10.1097/CEJ.0000000000000510] [PMID]

13. Tsushima F, Sakurai J, Uesugi A, Oikawa Y, Ohsako T, Mochizuki Y, et al. Malignant transformation of oral lichen planus: a retrospective study of 565 Japanese patients. BMC Oral Health2021;21(1):1-9.‏ [DOI:10.1186/s12903-021-01652-7] [PMID]

14. Lingam HT, Swetha P, Manyam R. Immunohistochemical evaluation of survivin in oral lichen planus and oral squamous cell carcinoma - a retrospective study. Med Pharm Rep. 2021;94(3):341-347. [DOI:10.15386/mpr-1746] [PMID] [PMCID]

15. Moosavi MS, Tavakol F. Literature review of cancer stem cells in oral lichen planus: a premalignant lesion. Stem Cell Investig 2021;8:25. [DOI:10.21037/sci-2020-049] [PMID] [PMCID]

16. Roy A. Molecular docking analysis of compounds from Andrographis paniculata with EGFR. Bioinformation. 2021;17(1):23-8 [DOI:10.6026/97320630017023] [PMID] [PMCID]

17. Cheng W-L, Feng P-H, Lee K-Y, Chen K-Y, Sun W-L, Van Hiep N, Luo C-S, Wu S-M. The role of EREG/EGFR pathway in tumor progression. Int J Mol Sci. 2021;22(23):12828 [DOI:10.3390/ijms222312828] [PMID] [PMCID]

18. Sabbah DA, Hajjo R, Sweidan K. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors. Curr Top Med Chem. 2020;20(10):815-834 [DOI:10.2174/1568026620666200303123102] [PMID]

19. Baba Y, Maeda T, Suzuki A, Takada S, Fujii M, Kato Y. Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci. 2017;18(2) [DOI:10.3390/ijms18020262] [PMID] [PMCID]

20. Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson E, Edwards P, et all. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125(6)650-669 [DOI:10.1016/j.oooo.2018.03.012] [PMID]

21. Tseng YK, Chen CF, Shu CW, Lee CH, Chou YT, Li YJ, et al. Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma. Int. J. Mol. Sci.2021;22(22): 12226. [DOI:10.3390/ijms222212226] [PMID] [PMCID]

22. Bhattacharyya S, Ray S, Saha D, Mustafi SM, Alam N, Sarkar A, et al. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in Oral leukoplakia- A cytochemistry based approach. Pathol. Res. Pract.2021; 218: 153287 [DOI:10.1016/j.prp.2020.153287] [PMID]

23. Shorghashti R, Sadri D, Farhadi S. Expression of Epidermal Growth Factor Receptor by Odontogenic Cysts: A comparative Study of Dentigerous Cyst and Odontogenic Keratocyst. J Res Dent Sci. 2020;17(2):127-136 [DOI:10.29252/jrds.17.2.127]

24. Ries J, Vairaktaris E, Agaimy A, Bechtold M, Gorecki P, Neukam FW, et al. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia. Oncol. Rep. 2013;30(3):1149-56 [DOI:10.3892/or.2013.2545] [PMID]

25. Ribeiro M, Teixeira SR, Azevedo MN, Fraga AC, Jr., Gontijo AP, Vencio EF. Expression of hypoxia-induced factor-1 alpha in early-stage and in metastatic oral squamous cell carcinoma. Tumour Biol . 2017;39(4) [DOI:10.1177/1010428317695527] [PMID]

26. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, Ayén Á, González-Ruiz L, Ruiz-Ávila I, Ramos-García P. Dysplasia in oral lichen planus: relevance, controversies and challenges. A position paper. Med Oral Patol Oral Cir Bucal. 2021;26(4):e541-e548 [DOI:10.4317/medoral.24610] [PMID] [PMCID]

27. Zotti F, Nocini R, Capocasale G, Bertossi D, Fior A, Peretti M, Manfrin E, Albanese M. Oral Lichen Planus: risk factors of malignant transformation and follow up. Ten years retrospective study. J Clin Exp Dent 2021;13(7):630-6 [DOI:10.4317/jced.57688] [PMID] [PMCID]

28. Mutafchieva MZ, Draganova-Filipova MN, Zagorchev PI, Tomov GT.Oral Lichen Planus - Known and Unknown: a Review. Folia Med (Plovdiv) 2018;60(4):528-535 [DOI:10.2478/folmed-2018-0017] [PMID]

29. Kumagai K, Horikawa T, Gotoh A, Yamane S, Yamada H, Kobayashi H, et al. Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(6):748-54. [DOI:10.1016/j.tripleo.2010.06.022] [PMID]

30. Cortes-Ramirez DA, Rodriguez-Tojo MJ, Coca-Meneses JC, Marichalar-Mendia X, Aguirre-Urizar JM. Epidermal growth factor receptor expression in different subtypes of oral lichenoid disease. Med Oral Patol Oral Cir Bucal. 2014;19(5):451-8. [DOI:10.4317/medoral.19452] [PMID] [PMCID]

31. Moorthy A, Venugopal DC, Shyamsundar V, Madhavan Y, Ravindran S, Kuppuloganathan M, et al. Identification of EGFR as a Biomarker in Saliva and Buccal Cells from Oral Submucous Fibrosis Patients-A Baseline Study. Diagnostics 2022;12(8),1935 [DOI:10.3390/diagnostics12081935] [PMID] [PMCID]

32. 2Adorno-Farias D, Badilla SM, Vidal GP, Fernandez-Ramires R. Epidermal Growth Factor Receptor (EGFR) is Overexpressed in Both Dysplasia and Neoplastic Oral Diseases. OMPJ 2022;13(2):73-78

33. Tan Y, Yan B, Xue L, Li Y, Luo X, Ji P. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma. Lipids Health Dis. 2017;16(1):73 [DOI:10.1186/s12944-017-0465-y] [PMID] [PMCID]

34. Bakhtiari S, Mortazavi H, Mehdipour M, Jafarian N, Ranjbari N, Rahmani S. Frequency of Head and Neck Squamous Cell Carcinomas and Related Variables in Southern Iran (Ahvaz City): 10-Year Retrospective Study. Asian Pac. J. Cancer Prev. 2017;18(2):375-9

35. Yang Q, Guo B, Sun H, Zhang J, Liu S, Hexige S, et al. Identification of the key genes implicated in the transformation of OLP to OSCC using RNA-sequencing. Oncol. Rep. 2017;37(4):2355-65 [DOI:10.3892/or.2017.5487] [PMID]

36. Lorini L, Bescós Atín C, Thavaraj S, Müller-Richter U, Alberola Ferranti M, Pamias Romero J, et al. Overview of oral potentially malignant disorders: from risk factors to specific therapies. Cancers 2021;13(15):3696 [DOI:10.3390/cancers13153696] [PMID] [PMCID]

37. Hwang JT, Gu YR, Shen M, Ralhan R, Walfish PG, Pritzker KP, et al. Individualized five-year risk assessment for oral premalignant lesion progression to cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(3):374-81 [DOI:10.1016/j.oooo.2016.11.004] [PMID]

38. Neville BW, Damm DD, Chi AC, Allen CM. Oral and maxillofacial pathology: Elsevier Health Sciences; 2016.

39. Ramos‐García P, González‐Moles MÁ, Warnakulasuriya S. Oral cancer development in lichen planus and related conditions-3.0 evidence level: a systematic review of systematic reviews. Oral Dis.2021;27(8):1919-1935.‏ [DOI:10.1111/odi.13812] [PMID]

40. Giuliani M, Troiano G, Cordaro M, Corsalini M, Gioco G, Lo Muzio L, et al. Rate of malignant transformation of oral lichen planus: A systematic review. Oral Dis.2019; 25(3):693-709.‏ [DOI:10.1111/odi.12885] [PMID]

41. Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: A meta-analysis of 20095 patient data. Oral Oncol. 2017;68:92-102 [DOI:10.1016/j.oraloncology.2017.03.012] [PMID]

42. Parakh MK, Ulaganambi Sh, Ashifa N, Premkumar R, Jain Amit L. Oral potentially malignant disorders. Eur. J. Cancer Prev. 2020. 29(1): 65-72 [DOI:10.1097/CEJ.0000000000000510] [PMID]

43. Tsushima F, Sakurai J, Uesugi A, Oikawa Y, Ohsako T, Mochizuki Y, et al. Malignant transformation of oral lichen planus: a retrospective study of 565 Japanese patients. BMC Oral Health2021;21(1):1-9.‏ [DOI:10.1186/s12903-021-01652-7] [PMID] [PMCID]

44. Lingam HT, Swetha P, Manyam R. Immunohistochemical evaluation of survivin in oral lichen planus and oral squamous cell carcinoma - a retrospective study. Med Pharm Rep. 2021;94(3):341-347. [DOI:10.15386/mpr-1746] [PMID] [PMCID]

45. Moosavi MS, Tavakol F. Literature review of cancer stem cells in oral lichen planus: a premalignant lesion. Stem Cell Investig 2021;8:25. [DOI:10.21037/sci-2020-049] [PMID] [PMCID]

46. Roy A. Molecular docking analysis of compounds from Andrographis paniculata with EGFR. Bioinformation. 2021;17(1):23-8 [DOI:10.6026/97320630017023] [PMID] [PMCID]

47. Cheng W-L, Feng P-H, Lee K-Y, Chen K-Y, Sun W-L, Van Hiep N, Luo C-S, Wu S-M. The role of EREG/EGFR pathway in tumor progression. Int J Mol Sci. 2021;22(23):12828 [DOI:10.3390/ijms222312828] [PMID] [PMCID]

48. Sabbah DA, Hajjo R, Sweidan K. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors. Curr Top Med Chem. 2020;20(10):815-834 [DOI:10.2174/1568026620666200303123102] [PMID]

49. Baba Y, Maeda T, Suzuki A, Takada S, Fujii M, Kato Y. Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci. 2017;18(2) [DOI:10.3390/ijms18020262] [PMID] [PMCID]

50. Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson E, Edwards P, et all. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125(6)650-669 [DOI:10.1016/j.oooo.2018.03.012] [PMID]

51. Tseng YK, Chen CF, Shu CW, Lee CH, Chou YT, Li YJ, et al. Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma. Int. J. Mol. Sci.2021;22(22): 12226. [DOI:10.3390/ijms222212226] [PMID] [PMCID]

52. Bhattacharyya S, Ray S, Saha D, Mustafi SM, Alam N, Sarkar A, et al. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in Oral leukoplakia- A cytochemistry based approach. Pathol. Res. Pract.2021; 218: 153287 [DOI:10.1016/j.prp.2020.153287] [PMID]

53. Shorghashti R, Sadri D, Farhadi S. Expression of Epidermal Growth Factor Receptor by Odontogenic Cysts: A comparative Study of Dentigerous Cyst and Odontogenic Keratocyst. J Res Dent Sci. 2020;17(2):127-136 [DOI:10.29252/jrds.17.2.127]

54. Ries J, Vairaktaris E, Agaimy A, Bechtold M, Gorecki P, Neukam FW, et al. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia. Oncol. Rep. 2013;30(3):1149-56 [DOI:10.3892/or.2013.2545] [PMID]

55. Ribeiro M, Teixeira SR, Azevedo MN, Fraga AC, Jr., Gontijo AP, Vencio EF. Expression of hypoxia-induced factor-1 alpha in early-stage and in metastatic oral squamous cell carcinoma. Tumour Biol . 2017;39(4) [DOI:10.1177/1010428317695527] [PMID]

56. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, Ayén Á, González-Ruiz L, Ruiz-Ávila I, Ramos-García P. Dysplasia in oral lichen planus: relevance, controversies and challenges. A position paper. Med Oral Patol Oral Cir Bucal. 2021;26(4):e541-e548 [DOI:10.4317/medoral.24610] [PMID] [PMCID]

57. Zotti F, Nocini R, Capocasale G, Bertossi D, Fior A, Peretti M, Manfrin E, Albanese M. Oral Lichen Planus: risk factors of malignant transformation and follow up. Ten years retrospective study. J Clin Exp Dent 2021;13(7):630-6 [DOI:10.4317/jced.57688] [PMID] [PMCID]

58. Mutafchieva MZ, Draganova-Filipova MN, Zagorchev PI, Tomov GT.Oral Lichen Planus - Known and Unknown: a Review. Folia Med (Plovdiv) 2018;60(4):528-535 [DOI:10.2478/folmed-2018-0017] [PMID]

59. Kumagai K, Horikawa T, Gotoh A, Yamane S, Yamada H, Kobayashi H, et al. Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(6):748-54. [DOI:10.1016/j.tripleo.2010.06.022] [PMID]

60. Cortes-Ramirez DA, Rodriguez-Tojo MJ, Coca-Meneses JC, Marichalar-Mendia X, Aguirre-Urizar JM. Epidermal growth factor receptor expression in different subtypes of oral lichenoid disease. Med Oral Patol Oral Cir Bucal. 2014;19(5):451-8. [DOI:10.4317/medoral.19452] [PMID] [PMCID]

61. Moorthy A, Venugopal DC, Shyamsundar V, Madhavan Y, Ravindran S, Kuppuloganathan M, et al. Identification of EGFR as a Biomarker in Saliva and Buccal Cells from Oral Submucous Fibrosis Patients-A Baseline Study. Diagnostics 2022;12(8),1935 [DOI:10.3390/diagnostics12081935] [PMID] [PMCID]

62. 2Adorno-Farias D, Badilla SM, Vidal GP, Fernandez-Ramires R. Epidermal Growth Factor Receptor (EGFR) is Overexpressed in Both Dysplasia and Neoplastic Oral Diseases. OMPJ 2022;13(2):73-78

63. Tan Y, Yan B, Xue L, Li Y, Luo X, Ji P. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma. Lipids Health Dis. 2017;16(1):73 [DOI:10.1186/s12944-017-0465-y] [PMID]

64. Bakhtiari S, Mortazavi H, Mehdipour M, Jafarian N, Ranjbari N, Rahmani S. Frequency of Head and Neck Squamous Cell Carcinomas and Related Variables in Southern Iran (Ahvaz City): 10-Year Retrospective Study. Asian Pac. J. Cancer Prev. 2017;18(2):375-9

65. Yang Q, Guo B, Sun H, Zhang J, Liu S, Hexige S, et al. Identification of the key genes implicated in the transformation of OLP to OSCC using RNA-sequencing. Oncol. Rep. 2017;37(4):2355-65 [DOI:10.3892/or.2017.5487] [PMID]

66. Lorini L, Bescós Atín C, Thavaraj S, Müller-Richter U, Alberola Ferranti M, Pamias Romero J, et al. Overview of oral potentially malignant disorders: from risk factors to specific therapies. Cancers 2021;13(15):3696 [DOI:10.3390/cancers13153696] [PMID] [PMCID]

67. Hwang JT, Gu YR, Shen M, Ralhan R, Walfish PG, Pritzker KP, et al. Individualized five-year risk assessment for oral premalignant lesion progression to cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(3):374-81 [DOI:10.1016/j.oooo.2016.11.004] [PMID]

68. Neville BW, Damm DD, Chi AC, Allen CM. Oral and maxillofacial pathology: Elsevier Health Sciences; 2016.

69. Ramos‐García P, González‐Moles MÁ, Warnakulasuriya S. Oral cancer development in lichen planus and related conditions-3.0 evidence level: a systematic review of systematic reviews. Oral Dis.2021;27(8):1919-1935.‏ [DOI:10.1111/odi.13812] [PMID]

70. Giuliani M, Troiano G, Cordaro M, Corsalini M, Gioco G, Lo Muzio L, et al. Rate of malignant transformation of oral lichen planus: A systematic review. Oral Dis.2019; 25(3):693-709.‏ [DOI:10.1111/odi.12885] [PMID]

71. Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: A meta-analysis of 20095 patient data. Oral Oncol. 2017;68:92-102 [DOI:10.1016/j.oraloncology.2017.03.012] [PMID]

72. Parakh MK, Ulaganambi Sh, Ashifa N, Premkumar R, Jain Amit L. Oral potentially malignant disorders. Eur. J. Cancer Prev. 2020. 29(1): 65-72 [DOI:10.1097/CEJ.0000000000000510] [PMID]

73. Tsushima F, Sakurai J, Uesugi A, Oikawa Y, Ohsako T, Mochizuki Y, et al. Malignant transformation of oral lichen planus: a retrospective study of 565 Japanese patients. BMC Oral Health2021;21(1):1-9.‏ [DOI:10.1186/s12903-021-01652-7] [PMID] [PMCID]

74. Lingam HT, Swetha P, Manyam R. Immunohistochemical evaluation of survivin in oral lichen planus and oral squamous cell carcinoma - a retrospective study. Med Pharm Rep. 2021;94(3):341-347. [DOI:10.15386/mpr-1746] [PMID] [PMCID]

75. Moosavi MS, Tavakol F. Literature review of cancer stem cells in oral lichen planus: a premalignant lesion. Stem Cell Investig 2021;8:25. [DOI:10.21037/sci-2020-049] [PMID] [PMCID]

76. Roy A. Molecular docking analysis of compounds from Andrographis paniculata with EGFR. Bioinformation. 2021;17(1):23-8 [DOI:10.6026/97320630017023] [PMID] [PMCID]

77. Cheng W-L, Feng P-H, Lee K-Y, Chen K-Y, Sun W-L, Van Hiep N, Luo C-S, Wu S-M. The role of EREG/EGFR pathway in tumor progression. Int J Mol Sci. 2021;22(23):12828 [DOI:10.3390/ijms222312828] [PMID] [PMCID]

78. Sabbah DA, Hajjo R, Sweidan K. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors. Curr Top Med Chem. 2020;20(10):815-834 [DOI:10.2174/1568026620666200303123102] [PMID]

79. Baba Y, Maeda T, Suzuki A, Takada S, Fujii M, Kato Y. Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci. 2017;18(2) [DOI:10.3390/ijms18020262] [PMID] [PMCID]

80. Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson E, Edwards P, et all. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125(6)650-669 [DOI:10.1016/j.oooo.2018.03.012] [PMID]

81. Tseng YK, Chen CF, Shu CW, Lee CH, Chou YT, Li YJ, et al. Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma. Int. J. Mol. Sci.2021;22(22): 12226. [DOI:10.3390/ijms222212226] [PMID] [PMCID]

82. Bhattacharyya S, Ray S, Saha D, Mustafi SM, Alam N, Sarkar A, et al. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in Oral leukoplakia- A cytochemistry based approach. Pathol. Res. Pract.2021; 218: 153287 [DOI:10.1016/j.prp.2020.153287] [PMID]

83. Shorghashti R, Sadri D, Farhadi S. Expression of Epidermal Growth Factor Receptor by Odontogenic Cysts: A comparative Study of Dentigerous Cyst and Odontogenic Keratocyst. J Res Dent Sci. 2020;17(2):127-136 [DOI:10.29252/jrds.17.2.127]

84. Ries J, Vairaktaris E, Agaimy A, Bechtold M, Gorecki P, Neukam FW, et al. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia. Oncol. Rep. 2013;30(3):1149-56 [DOI:10.3892/or.2013.2545] [PMID]

85. Ribeiro M, Teixeira SR, Azevedo MN, Fraga AC, Jr., Gontijo AP, Vencio EF. Expression of hypoxia-induced factor-1 alpha in early-stage and in metastatic oral squamous cell carcinoma. Tumour Biol . 2017;39(4) [DOI:10.1177/1010428317695527] [PMID]

86. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, Ayén Á, González-Ruiz L, Ruiz-Ávila I, Ramos-García P. Dysplasia in oral lichen planus: relevance, controversies and challenges. A position paper. Med Oral Patol Oral Cir Bucal. 2021;26(4):e541-e548 [DOI:10.4317/medoral.24610] [PMID] [PMCID]

87. Zotti F, Nocini R, Capocasale G, Bertossi D, Fior A, Peretti M, Manfrin E, Albanese M. Oral Lichen Planus: risk factors of malignant transformation and follow up. Ten years retrospective study. J Clin Exp Dent 2021;13(7):630-6 [DOI:10.4317/jced.57688] [PMID] [PMCID]

88. Mutafchieva MZ, Draganova-Filipova MN, Zagorchev PI, Tomov GT.Oral Lichen Planus - Known and Unknown: a Review. Folia Med (Plovdiv) 2018;60(4):528-535 [DOI:10.2478/folmed-2018-0017] [PMID]

89. Kumagai K, Horikawa T, Gotoh A, Yamane S, Yamada H, Kobayashi H, et al. Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(6):748-54. [DOI:10.1016/j.tripleo.2010.06.022] [PMID]

90. Cortes-Ramirez DA, Rodriguez-Tojo MJ, Coca-Meneses JC, Marichalar-Mendia X, Aguirre-Urizar JM. Epidermal growth factor receptor expression in different subtypes of oral lichenoid disease. Med Oral Patol Oral Cir Bucal. 2014;19(5):451-8. [DOI:10.4317/medoral.19452] [PMID] [PMCID]

91. Moorthy A, Venugopal DC, Shyamsundar V, Madhavan Y, Ravindran S, Kuppuloganathan M, et al. Identification of EGFR as a Biomarker in Saliva and Buccal Cells from Oral Submucous Fibrosis Patients-A Baseline Study. Diagnostics 2022;12(8),1935 [DOI:10.3390/diagnostics12081935] [PMID] [PMCID]

92. 2Adorno-Farias D, Badilla SM, Vidal GP, Fernandez-Ramires R. Epidermal Growth Factor Receptor (EGFR) is Overexpressed in Both Dysplasia and Neoplastic Oral Diseases. OMPJ 2022;13(2):73-78

93. Tan Y, Yan B, Xue L, Li Y, Luo X, Ji P. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma. Lipids Health Dis. 2017;16(1):73 [DOI:10.1186/s12944-017-0465-y] [PMID] [PMCID]

94. Bakhtiari S, Mortazavi H, Mehdipour M, Jafarian N, Ranjbari N, Rahmani S. Frequency of Head and Neck Squamous Cell Carcinomas and Related Variables in Southern Iran (Ahvaz City): 10-Year Retrospective Study. Asian Pac. J. Cancer Prev. 2017;18(2):375-9

95. Yang Q, Guo B, Sun H, Zhang J, Liu S, Hexige S, et al. Identification of the key genes implicated in the transformation of OLP to OSCC using RNA-sequencing. Oncol. Rep. 2017;37(4):2355-65 [DOI:10.3892/or.2017.5487] [PMID]

96. Lorini L, Bescós Atín C, Thavaraj S, Müller-Richter U, Alberola Ferranti M, Pamias Romero J, et al. Overview of oral potentially malignant disorders: from risk factors to specific therapies. Cancers 2021;13(15):3696 [DOI:10.3390/cancers13153696] [PMID] [PMCID]

97. Hwang JT, Gu YR, Shen M, Ralhan R, Walfish PG, Pritzker KP, et al. Individualized five-year risk assessment for oral premalignant lesion progression to cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(3):374-81 [DOI:10.1016/j.oooo.2016.11.004] [PMID]

98. Neville BW, Damm DD, Chi AC, Allen CM. Oral and maxillofacial pathology: Elsevier Health Sciences; 2016.

99. Ramos‐García P, González‐Moles MÁ, Warnakulasuriya S. Oral cancer development in lichen planus and related conditions-3.0 evidence level: a systematic review of systematic reviews. Oral Dis.2021;27(8):1919-1935.‏ [DOI:10.1111/odi.13812] [PMID]

100. Giuliani M, Troiano G, Cordaro M, Corsalini M, Gioco G, Lo Muzio L, et al. Rate of malignant transformation of oral lichen planus: A systematic review. Oral Dis.2019; 25(3):693-709.‏ [DOI:10.1111/odi.12885]

101. Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: A meta-analysis of 20095 patient data. Oral Oncol. 2017;68:92-102 [DOI:10.1016/j.oraloncology.2017.03.012] [PMID]

102. Parakh MK, Ulaganambi Sh, Ashifa N, Premkumar R, Jain Amit L. Oral potentially malignant disorders. Eur. J. Cancer Prev. 2020. 29(1): 65-72 [DOI:10.1097/CEJ.0000000000000510] [PMID]

103. Tsushima F, Sakurai J, Uesugi A, Oikawa Y, Ohsako T, Mochizuki Y, et al. Malignant transformation of oral lichen planus: a retrospective study of 565 Japanese patients. BMC Oral Health2021;21(1):1-9.‏ [DOI:10.1186/s12903-021-01652-7] [PMID] [PMCID]

104. Lingam HT, Swetha P, Manyam R. Immunohistochemical evaluation of survivin in oral lichen planus and oral squamous cell carcinoma - a retrospective study. Med Pharm Rep. 2021;94(3):341-347. [DOI:10.15386/mpr-1746] [PMID] [PMCID]

105. Moosavi MS, Tavakol F. Literature review of cancer stem cells in oral lichen planus: a premalignant lesion. Stem Cell Investig 2021;8:25. [DOI:10.21037/sci-2020-049] [PMID] [PMCID]

106. Roy A. Molecular docking analysis of compounds from Andrographis paniculata with EGFR. Bioinformation. 2021;17(1):23-8 [DOI:10.6026/97320630017023] [PMID] [PMCID]

107. Cheng W-L, Feng P-H, Lee K-Y, Chen K-Y, Sun W-L, Van Hiep N, Luo C-S, Wu S-M. The role of EREG/EGFR pathway in tumor progression. Int J Mol Sci. 2021;22(23):12828 [DOI:10.3390/ijms222312828] [PMID] [PMCID]

108. Sabbah DA, Hajjo R, Sweidan K. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors. Curr Top Med Chem. 2020;20(10):815-834 [DOI:10.2174/1568026620666200303123102] [PMID]

109. Baba Y, Maeda T, Suzuki A, Takada S, Fujii M, Kato Y. Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci. 2017;18(2) [DOI:10.3390/ijms18020262] [PMID] [PMCID]

110. Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson E, Edwards P, et all. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125(6)650-669 [DOI:10.1016/j.oooo.2018.03.012]

111. Tseng YK, Chen CF, Shu CW, Lee CH, Chou YT, Li YJ, et al. Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma. Int. J. Mol. Sci.2021;22(22): 12226. [DOI:10.3390/ijms222212226] [PMID] [PMCID]

112. Bhattacharyya S, Ray S, Saha D, Mustafi SM, Alam N, Sarkar A, et al. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in Oral leukoplakia- A cytochemistry based approach. Pathol. Res. Pract.2021; 218: 153287 [DOI:10.1016/j.prp.2020.153287] [PMID]

113. Shorghashti R, Sadri D, Farhadi S. Expression of Epidermal Growth Factor Receptor by Odontogenic Cysts: A comparative Study of Dentigerous Cyst and Odontogenic Keratocyst. J Res Dent Sci. 2020;17(2):127-136 [DOI:10.29252/jrds.17.2.127]

114. Ries J, Vairaktaris E, Agaimy A, Bechtold M, Gorecki P, Neukam FW, et al. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia. Oncol. Rep. 2013;30(3):1149-56 [DOI:10.3892/or.2013.2545] [PMID]

115. Ribeiro M, Teixeira SR, Azevedo MN, Fraga AC, Jr., Gontijo AP, Vencio EF. Expression of hypoxia-induced factor-1 alpha in early-stage and in metastatic oral squamous cell carcinoma. Tumour Biol . 2017;39(4) [DOI:10.1177/1010428317695527] [PMID]

116. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, Ayén Á, González-Ruiz L, Ruiz-Ávila I, Ramos-García P. Dysplasia in oral lichen planus: relevance, controversies and challenges. A position paper. Med Oral Patol Oral Cir Bucal. 2021;26(4):e541-e548 [DOI:10.4317/medoral.24610] [PMID] [PMCID]

117. Zotti F, Nocini R, Capocasale G, Bertossi D, Fior A, Peretti M, Manfrin E, Albanese M. Oral Lichen Planus: risk factors of malignant transformation and follow up. Ten years retrospective study. J Clin Exp Dent 2021;13(7):630-6 [DOI:10.4317/jced.57688] [PMID] [PMCID]

118. Mutafchieva MZ, Draganova-Filipova MN, Zagorchev PI, Tomov GT.Oral Lichen Planus - Known and Unknown: a Review. Folia Med (Plovdiv) 2018;60(4):528-535 [DOI:10.2478/folmed-2018-0017] [PMID]

119. Kumagai K, Horikawa T, Gotoh A, Yamane S, Yamada H, Kobayashi H, et al. Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(6):748-54. [DOI:10.1016/j.tripleo.2010.06.022] [PMID]

120. Cortes-Ramirez DA, Rodriguez-Tojo MJ, Coca-Meneses JC, Marichalar-Mendia X, Aguirre-Urizar JM. Epidermal growth factor receptor expression in different subtypes of oral lichenoid disease. Med Oral Patol Oral Cir Bucal. 2014;19(5):451-8. [DOI:10.4317/medoral.19452] [PMID] [PMCID]